Identifying brain markers for addiction cravings and drug use
Neuromarkers for craving and drug use
This study is looking to find new ways to measure brain signals that can help us understand and predict cravings for substances like cocaine, alcohol, and tobacco, which could lead to better support for people dealing with addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11161100 on NIH RePORTER |
What this research studies
This research focuses on developing and validating neuromarkers, which are measurable indicators in the brain that can help understand addiction and cravings. Using advanced techniques like machine learning and fMRI, the study aims to create a reliable neuromarker that predicts cravings for substances such as cocaine, alcohol, and tobacco. By analyzing a large database of existing studies, the researchers will assess how well these markers can predict cravings across different demographics and conditions. This could lead to better treatment strategies for individuals struggling with substance use disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with substance use disorders, particularly those involving cocaine, alcohol, or tobacco.
Not a fit: Patients who do not have substance use disorders or those who are not actively seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for addiction by providing personalized insights into cravings and relapse risk.
How similar studies have performed: Previous research has shown promising results in using neuromarkers for predicting cravings and relapse in addiction, indicating a potential for success in this approach.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Kober, Hedy — University of California Berkeley
- Study coordinator: Kober, Hedy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.